Clinical Trial Update: The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating metformin as an adjunct to conventional therapy for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Sadat City University | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED